Skip to main content

PERRIGO Co plc

For the period ended Mar 28, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 28, 2026 · Filed May 6, 2026

PRGO$16.95+6.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Derivative Instruments and Hedging Activities

NOTE 10 -DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

Interest Rate Swaps

We have $1.2 billion notional amount of variable-to-fixed interest rate swaps used to economically hedge interest rate risk on a substantial portion of our Senior Secured Credit Facilities (as defined in Note 11). The interest rate

Note 10

swaps were designated as cash flow hedges to fix the variable interest rate. As a designated cash flow hedge, changes in fair value will be deferred in AOCI and recognized within Interest expense, net when interest is paid on the Senior Secured Credit Facilities.

As of March 28, 2026, the designated instruments used to hedge the exposure to variable interest on the Senior Secured Credit Facilities totaled $1.2 billion notional amount of which $487.5 million and $712.5 million notional amounts are effective through April 2027 and April 2029, respectively.

As of March 28, 2026, the undesignated economically offsetting interest rate swaps totaling$600.0 million are effective through April 2029.

Cross-currency Swaps

We have $2.3 billion notional amount fixed-for-fixed cross-currency interest rate swaps designated as net investment hedges to hedge the European Euro (“EUR”) currency exposure of our investment in European operations. As designated net investment hedges, gains and losses related to the EUR spot exchange rate will be deferred within the Cumulative Translation Adjustment, a component of AOCI, and recognized in the Condensed Consolidated Statements of Operations when the hedged EUR net investment is substantially liquidated. Gains and losses on excluded components (e.g., interest differentials) will be recorded in Interest expense, net on a systematic and rational basis.

As of March 28, 2026, of the total $2.3 billion notional amount, $1.0 billion, $300.0 million, $450.0 million, $380.0 million, and $200.0 million notional amounts are effective through April 2027, September 2028, November 2030, December 2030, and March 2033, respectively.

Other Hedging Instruments

The €350.0 million 2032 Notes (as defined in Note 11) are designated as a net investment hedge on our investment in European operations.

As a designated net investment hedge, gains and losses related to the EUR spot exchange rate will be deferred within the Cumulative Translation Adjustment, a component of AOCI, and recognized in the Condensed Consolidated Statements of Operations when the hedged EUR net investment is substantially liquidated.

Note 10

Foreign Currency Forwards

Notional amounts of foreign currency forward contracts were as follows (in millions):

March 28, 2026December 31, 2025
British Pound (GBP)$163.2$148.1
European Euro (EUR)155.550.1
United States Dollar (USD)114.6160.6
Danish Krone (DKK)46.056.8
Swedish Krona (SEK)36.648.6
Polish Zloty (PLZ)32.343.3
Canadian Dollar (CAD)22.421.2
Hungarian Forint (HUF)15.411.0
Chinese Yuan (CNH)14.216.3
Norwegian Krone (NOK)5.34.6
Other(1)29.718.1
Total$635.3$578.7

(1) Number consists of notional amounts of various currencies, none of which individually exceed $10.0 million in either year presented.

The maximum term of our forward currency exchange contracts is 60 months.

On August 1, 2025, we entered into a deal-contingent EUR/USD forward contract of €300 million to hedge foreign exchange risk related to the proceeds expected for the planned divestiture of our Dermacosmetics Business (refer to Note 3 for additional details). The contract is contingent on the successful closing of the transaction. If the divestiture does not close by January 13, 2027, the derivative will be terminated with no settlement obligation.

Effects of Derivatives on the Financial Statements

The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects.

The balance sheet location and gross fair value of our derivative instruments were as follows (in millions):

Balance Sheet LocationMarch 28, 2026December 31, 2025
Designated derivative assets:
Foreign currency forward contractsPrepaid expenses and other current assets$0.6$0.3
Interest rate swap agreementsOther non-current assets2.81.1
Total designated derivative assets$3.4$1.4
Non-designated derivative assets:
Foreign currency forward contractsPrepaid expenses and other current assets$5.0$2.1
Total non-designated derivatives$5.0$2.1
Designated derivative liabilities:
Foreign currency forward contractsOther accrued liabilities$1.7$1.1
Cross-currency swapsOther non-current liabilities211.1265.6
Interest rate swap agreementsOther non-current liabilities13.422.0
Total designated derivative liabilities$226.2$288.7
Non-designated derivative liabilities:
Foreign currency forward contractsOther accrued liabilities$3.1$13.4
Interest rate swap agreementsOther non-current liabilities10.010.8
Total non-designated derivative liabilities$13.1$24.2

Note 10

The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows (in millions):

Three Months Ended
Non-Designated DerivativesIncome Statement LocationMarch 28, 2026March 29, 2025
Foreign currency forward contractsOther (income), net$2.2$(4.8)
Interest rate swap agreementsInterest expense, net$—$0.2

The following tables summarize the effect of derivative instruments designated as hedging instruments in AOCI (in millions):

Gain or (Loss) Reclassified from AOCI into Earnings
Related to Amounts Included in Effectiveness Testing · Related to Amounts Excluded from Effectiveness Testing
Amount of Gain or (Loss) Recognized in OCI(1) · Location of Gain or (Loss) · Amount Reclassified(2) · Location of Gain or (Loss) · Amount Reclassified(2)
Cash flow hedges
Interest rate swap agreements$9.8Interest expense, net$1.2Interest expense, net$—
Foreign currency forward contracts(1.0)Net sales—Net sales0.1
Cost of sales(0.7)Cost of sales—
Total Cash flow hedges$8.8$0.5$0.1
Net investment hedges
Cross-currency swaps$55.2Interest expense, net$8.2
Euro Notes Due 20328.2
Total Net investment hedges$63.4$8.2
Cash flow hedges
Interest rate swap agreements$(11.1)Interest expense, net$4.7Interest expense, net$—
Foreign currency forward contracts0.5Net sales—Net sales(0.1)
Cost of sales0.4Cost of sales0.1
Total Cash flow hedges$(10.6)$5.1$—
Net investment hedges
Cross-currency swaps$59.9Interest expense, net$9.4
Euro Notes Due 2032(16.4)
Total Net investment hedges$43.5$9.4

(1) Net income of $36.9 million is expected to be reclassified out of AOCI into earnings during the next 12 months.

(2) For additional details about the effect of the amounts reclassified from AOCI refer to Note 13.

Note 10

The classification and amount of gain/(loss) recognized in earnings related to fair value and hedging relationships on the Condensed Consolidated Statement of Operations were as follows (in millions):

Net SalesCost of SalesInterest Expense, netOther (Income) Expense, net
Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded$969.2$643.7$40.8$(6.0)
Gain (loss) on cash flow hedging relationships
Foreign currency forward contracts
Amount of gain reclassified from AOCI into earnings$—$(0.7)$—$—
Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach$0.1$—$—$—
Interest rate swap agreements
Amount of gain reclassified from AOCI into earnings$—$—$1.2$—
Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded$1,043.9$651.6$39.0$(0.4)
Gain (loss) on cash flow hedging relationships
Foreign currency forward contracts
Amount of gain reclassified from AOCI into earnings$—$0.4$—$—
Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach$(0.1)$0.1$—$—
Interest rate swap agreements
Amount of gain reclassified from AOCI into earnings$—$—$4.7$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.